Nurse Practitioner, Family · Wyomissing, PA
NPI
1710408315
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1991 State Hill Rd
Wyomissing, PA, 19610
Phone (484) 628-4270
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
500 services
Medicare patients, 2024
149
Average age 70
Drug cost, 2024
$1.8M
3,333 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan K Sporre was code 99232 (hospital e&m - subsequent), 156 times for 55 patients. In total Megan K Sporre billed 500 services in 10 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 156 | 55 | $51.06 | $7,966 |
| 99214 Office E&M - Established | Facility | 133 | 64 | $55.63 | $7,399 |
| 95251 Test - Miscellaneous | Facility | 100 | 46 | $20.26 | $2,026 |
| 99215 Office E&M - Established | Facility | 48 | 30 | $86.15 | $4,135 |
| 99233 Hospital E&M - Subsequent | Facility | 35 | 26 | $76.99 | $2,695 |
| 99205 Office E&M - New | Facility | 11 | 11 | $117.73 | $1,295 |
By year: 2022 $21K for 399 services; 2023 $32K for 644 services; 2024 $26K for 500 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 77 | 49 | $9.31 | $717 |
Medicare prescription drug claims, 2024
In 2024, the drug Megan K Sporre prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 390 prescriptions and refills. In total Megan K Sporre wrote 3,333 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 390 | 857 | 131 | $52K |
| Trulicity Dulaglutide | 242 | 374 | 61 | $359K |
| Ozempic Semaglutide | 203 | 279 | 60 | $252K |
| Metformin Hcl Generic | 199 | 436 | 72 | $1,265 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 198 | 446 | 82 | $22K |
| Jardiance Empagliflozin | 182 | 307 | 50 | $176K |
| Metformin Hcl Er Metformin Hcl | 170 | 332 | 43 | $3,242 |
| Novolog Flexpen Insulin Aspart | 146 | 310 | 64 | $54K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 103 | 175 | 39 | $27K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 101 | 217 | 29 | $41K |
| Farxiga Dapagliflozin Propanediol | 99 | 173 | 31 | $94K |
| Mounjaro Tirzepatide | 90 | 96 | 20 | $101K |
| Humalog Kwikpen U-100 Insulin Lispro | 67 | 157 | 26 | $40K |
| Insulin Aspart Flexpen Insulin Aspart | 64 | 98 | 28 | $14K |
| True Comfort Safety Pen Needle Pen Needle, Diabetic, Safety | 56 | 97 | 11 | $13K |
Brand drugs: 2,215 claims; generic drugs: 588 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Megan K Sporre were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.